2.2. PI-3K/AKT and MAPK ERK1/2 Signaling Pathways Drive Heregulin-Stimulated, SBREP-Dependent FASN Gene Expression in Breast Cancer Cells. This evidence concerns the gene MAPK3 and breast carcinoma.